OREANDA-NEWS. On 17 March 2008 was announced, that in response to the circulating information on potential M&A deals that might involve Russian pharma market research companies Pharmexpert declares the nonparticipation in such processes and absence of such plans.

Through the end of April 2008, the company plans to complete the transfer of its customers to a new software product that will provide for a flexible and rapid report generation based on the full spectrum of Pharmexpert’s databases.

With regard to the drugstore sampling in Russia, the company plans on expanding the number of drugstores in a sample to 7000 (proceeding from the retail chain structural specifics) through the end of 2008. Thus the number of the regions covered in detail will grow. Similar improvements are provided for most CIS-based projects.

The company is sure that it will be able to strengthen its leadership in the pharma market analysis segment.